Agilent Technologies, Inc. (A) Stock

About Agilent Technologies, Inc.

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.

Agilent Technologies, Inc. is led by CEO Padraig McDonnell, employs 17,900 people, headquartered in Santa Clara, US, publicly traded since 1999.

Agilent Technologies, Inc. (A) stock trades at $137.39 with a market capitalization of $38.80B. The stock is valued at a price-to-earnings (P/E) ratio of 25.52, price-to-book of 4.73, price-to-sales of 5.01. Over the past 52 weeks the stock has ranged between $103.16 and $160.27, and currently trades 14.3% below its 52-week high. It pays a dividend yielding 0.59%.

On profitability, Agilent Technologies, Inc. generates a return on equity (ROE) of 19.95%, above the typical market average, return on capital employed of 21.94%, an operating margin of 21.29%, a net profit margin of 19.55%.

In its most recent fiscal year, Agilent Technologies, Inc. reported annual revenue of $6.9B, net profit of $1.3B, revenue has compounded at 5.4% a year over the last five years, profit at 12.6% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.47 — a conservative balance sheet with little leverage risk, a current ratio of 1.96, total assets of $12.7B, $1.8B in cash and equivalents.

A has an average daily trading volume of 2,415,485 shares, a beta of 1.26.

Official website: www.agilent.com